Literature DB >> 1849878

Patterns of survival with AIDS in the United States.

J Piette1, V Mor, J Fleishman.   

Abstract

We examined patterns of survival with AIDS (acquired immune deficiency syndrome) using the Centers for Disease Control (CDC) "AIDS Public Information Data Set." Analyses used a census of 23,271 cases diagnosed between January 1, 1984 and December 31, 1986. Three Cox proportional hazards models were fit to the data. The first used clinical and demographic parameters only in an effort to replicate Rothenberg's analysis of survival for patients diagnosed in New York City prior to 1986. The second model included variables that capture the effect of time of diagnosis in order to determine whether temporal trends exist. The third model included variables indicating the geographic region from which the cases were reported. The results of these models support earlier findings of demographic and clinical survival correlates. Controlling for covariates, patients diagnosed during 1986 lived significantly longer than those diagnosed earlier; the difference was most profound when Pneumocystis carinii (PCP) was present. Last, we observed large regional differences; their implications for health services planning are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1849878      PMCID: PMC1069811     

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  16 in total

1.  Community-based case management for persons with AIDS.

Authors:  V Mor; J Piette; J Fleishman
Journal:  Health Aff (Millwood)       Date:  1989       Impact factor: 6.301

2.  Review of death certificates to assess completeness of AIDS case reporting.

Authors:  A M Hardy; E T Starcher; W M Morgan; J Druker; A Kristal; J M Day; C Kelly; E Ewing; J W Curran
Journal:  Public Health Rep       Date:  1987 Jul-Aug       Impact factor: 2.792

Review 3.  Acquired immune deficiency syndrome in children. Current problems and therapeutic considerations.

Authors:  P A Pizzo; J Eddy; J Faloon
Journal:  Am J Med       Date:  1988-08-29       Impact factor: 4.965

4.  The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP.

Authors:  C L Bennett; J B Garfinkle; S Greenfield; D Draper; W Rogers; C Mathews; D E Kanouse
Journal:  JAMA       Date:  1989-05-26       Impact factor: 56.272

5.  Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom.

Authors:  G Marasca; M McEvoy
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-28

6.  Survival patterns of the first 500 patients with AIDS in San Francisco.

Authors:  P Bacchetti; D Osmond; R E Chaisson; S Dritz; G W Rutherford; L Swig; A R Moss
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

7.  Underreporting of AIDS cases in South Carolina, 1986 and 1987.

Authors:  G A Conway; B Colley-Niemeyer; C Pursley; C Cruz; S Burt; P Rion; C W Heath
Journal:  JAMA       Date:  1989-11-24       Impact factor: 56.272

8.  Hospital charges for people with AIDS in Washington State: utilization of a statewide hospital discharge data base.

Authors:  W E Lafferty; S G Hopkins; J Honey; J D Harwell; P C Shoemaker; J M Kobayashi
Journal:  Am J Public Health       Date:  1988-08       Impact factor: 9.308

9.  Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City.

Authors:  R Rothenberg; M Woelfel; R Stoneburner; J Milberg; R Parker; B Truman
Journal:  N Engl J Med       Date:  1987-11-19       Impact factor: 91.245

10.  Medical costs of ambulatory patients with AIDS-related complex (ARC) and/or generalized lymphadenopathy syndrome (GLS) related to HIV infection, 1984-85.

Authors:  G R Seage; S Landers; K H Mayer; M A Barry; G A Lamb; A M Epstein
Journal:  Am J Public Health       Date:  1988-08       Impact factor: 9.308

View more
  1 in total

1.  The effects of immune status and race on health service use among people with HIV disease.

Authors:  J D Piette; V Mor; K Mayer; S Zierler; T Wachtel
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.